47045-GIN-T-PLAN-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Tuberculosis - Guinea (01-Jan-2017-31-Dec-2017)</narrative> Guinea, Tuberculosis, Plan International, Inc. Goal: Significantly reduce the TB disease burden among the population of Guinea, with a view to attaining the targets of the global post-2015 End TB Strategy. Objectives: Detect rifampicin resistance among at least 80 percent of re-treatment cases in 2017 and place at least 90 percent of confirmed RR-TB/MDR-TB cases on second-line treatment; Extend community DOTS from 14 to 20 prefectures (including six severely affected by EVD), so that at least 10 percent of TB patients are referred by a CHW in 2017; Increase the treatment success rate from 78.2 percent in 2014 to 84 percent in 2017; Screen at least 85 percent of TB patients for HIV and place at least 90 percent of co-infected patients on ARVs in 2017; Strengthen TB diagnosis capacity and quality and scale up screening among vulnerable populations and at-risk groups, with a view to increasing the number of TB cases detected and placed on treatment by 2.2 percent each year; Strengthen the NTCP’s management and monitoring capacities, so that at least 95 percent of planned program activities under the grant, and for which funding is available in the country, are completed in 2017. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. Plan International, Inc. The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Tarek Elshimi Fund Portfolio Manager +41 58 791 1700 tarek.elshimi@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Guinea Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 3504935.00 Global Fund commitment to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 10000.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 617937.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 531706.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 910466.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 651727.68 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 170403.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 25000.00 Global Fund commitment to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 25000.00 Global Fund disbursement to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. -612695.32 Global Fund commitment to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. 44077.65 Funds returned to the Global Fund from GIN-T-PLANP01. Plan International, Inc. The Global Fund to Fight AIDS, Tuberculosis and Malaria -44077.65 Global Fund commitment to GIN-T-PLANP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Plan International, Inc. <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 357; Denominator: 675. Numerator: 282; Denominator: 353. Numerator: 240; Denominator: 250. Numerator: 565; Denominator: 706. Numerator: 444; Denominator: 542. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 102; Denominator: 116. Numerator: 87; Denominator: 108. Numerator: 106; Denominator: 121. Numerator: 92; Denominator: 108. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Module: TB care and prevention. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 4970; Denominator: 6255. Numerator: 3129; Denominator: 3725. Numerator: 3317; Denominator: 4073. Numerator: 6257; Denominator: 7449. Numerator: 6571; Denominator: 7989. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1507; Denominator: 2183. Numerator: 1168; Denominator: 1298. Numerator: 1178; Denominator: 1378. Numerator: 2336; Denominator: 2595. Numerator: 2551; Denominator: 2906. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 9044; Denominator: 12168. Numerator: 5406; Denominator: 6360. Numerator: 5703; Denominator: 6816. Numerator: 10813; Denominator: 12721. Numerator: 11513; Denominator: 13786.